Physician profile
Guy Young
NPI 1124238878
$2,588.81
in general payments reported to CMS, 2019-2025
10 companies · $221 in 2025
The $221 reported for 2025 was more than what 82% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,291 · 2022: $40.22 · 2023: $19.74 · 2024: $16.37 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $257.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $2,250.00 | 2021 | |
| Genentech, INC. | $113.75 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $92.86 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $24.27 | 2021 | |
| Amgen INC. | $21.32 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $19.74 | 2023 | Opdivo |
| Alexion Pharmaceuticals, INC. | $18.90 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.16 | 2021 | |
| Cordis US Corp. | $16.37 | 2024 | S.M.A.R.T. |
| Boston Scientific Corporation | $14.44 | 2025 | Enroute Transcarotid Neuroprotection System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.